Pfizer issues first Trovan payouts; Watson plots new $23.5M distribution center;

@FiercePharma: 90% of surveyed MDs know about Incivek and Victrelis. Majority prescribe both. Report #sermosurveys | Follow @FiercePharma

> Pfizer made its first payments to parents of Nigerian children who died during a controversial trial of the meningitis drug Trovan. Report

> Watson Pharmaceuticals plans to build a $23.5 million, 234,000-square-foot distribution center in Mississippi to replace a leased facility in Ohio. Seventy people will be employed at the new building. Story

> Osmotica Pharmaceuticals plans to invest $20 million in a new manufacturing and R&D operation in Georgia, hiring 156 employees to take over work now farmed out to 5 contract manufacturers. News

> As expected, Avanir Pharmaceuticals sued generics makers Actavis and Par Pharmaceuticals to protect the patents on its new drug Nuedexta. Article 

> Generics maker Lannett has relaunched its morphine product with an FDA approval after the agency ordered it to stop selling the drug without clearance. Item 

> United Laboratories International, the largest penicillin producer in China, is shopping for $156 million in financing. Story

> The Mexican government certified two vaccines from China's Sinovac, including its seasonal flu shot. News

Biotech News

@FierceBiotech: VC groups proffer $14.4M to back Yaupon's lymphoma drug app. Item | Follow @FierceBiotech

@JohnCFierce: This is pretty cool. Blurring electronics and biology, Air Force and NSF create light "smart skin." Piece | Follow @JohnCFierce

@RyanMFierce: Osmotica Pharma is heading down to Georgia, putting R&D/manufacturing facility in Marietta. Story | Follow @RyanMFierce

@MaureenFierce: Dendreon's a Broken IPO, Again. News | Follow @MaureenFierce

> Proteon Therapeutics grabs $15.2M financing. News

> MannKind rallies on FDA nod for inhaled insulin trials. Item 

> Report: Biotech M&A activity jumps in 1H 2011. Report 

> LaMattina gives insider's view of R&D 'upheaval' at Pfizer. Article

> Icahn eyes leaner drug research at Forest, Bloomberg reports. Story 

And Finally... A broader mandate for meningitis vaccination in Texas is ruffling some conservative feathers. Report